Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study

BACKGROUND: Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events. OBJECTIVES: To evaluate the efficacy and safety of first-line tocilizumab in PMR. METHODS: In a prospective open-label study (ClinicalTrials.gov: NCT01713842), 20 glucocorticoid-free...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Rheum Dis
Main Authors: Devauchelle-Pensec, Valérie, Berthelot, Jean Marie, Cornec, Divi, Renaudineau, Yves, Marhadour, Thierry, Jousse-Joulin, Sandrine, Querellou, Solène, Garrigues, Florent, De Bandt, Michel, Gouillou, Maelenn, Saraux, Alain
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Clinical and Epidemiological Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4975852/
https://ncbi.nlm.nih.gov/pubmed/26929219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2015-208742
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados